InMed Pharmaceuticals Inc. ($INM)
Filing Information
| Accession Number | 0001213900-26-075144 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 2, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
6,551
Total Value
$10,148.05
P&L
-17.4% ($1,762.77)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Shares | โ | Jun 30, 2026 | Purchase | 545 | $1.54 | $839.30 | 718,989 | Indirect | By Vivo Opportunity Fund Holdings, L.P. | View Details | |
10% Owner | Common Shares | โ | Jun 30, 2026 | Purchase | 55 | $1.54 | $84.70 | 72,590 | Indirect | By Vivo Opportunity Cayman Fund, L.P. | View Details | |
10% Owner | Common Shares | โ | Jul 1, 2026 | Purchase | 3,946 | $1.55 | $6,116.30 | 722,935 | Indirect | By Vivo Opportunity Fund Holdings, L.P. | View Details | |
10% Owner | Common Shares | โ | Jul 1, 2026 | Purchase | 398 | $1.55 | $616.90 | 72,988 | Indirect | By Vivo Opportunity Cayman Fund, L.P. | View Details | |
10% Owner | Common Shares | โ | Jul 2, 2026 | Purchase | 1,460 | $1.55 | $2,263.00 | 724,395 | Indirect | By Vivo Opportunity Fund Holdings, L.P. | View Details | |
10% Owner | Common Shares | โ | Jul 2, 2026 | Purchase | 147 | $1.55 | $227.85 | 73,135 | Indirect | By Vivo Opportunity Cayman Fund, L.P. | View Details |